About: Effects of Specially Designed Fermented Milk Product Containing Probiotic Lactobacillus casei DN-114 001 and the Eradication of H. pylori in Children     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Cíle: určit účinnost trojité terapie spojené se speciálně vytvořeným produktem z fermentovaného mléka obsahujícího probiotické kultury kmene Lactobacillus casei (L. casei) DN-114 001 na eradikaci H.pylori u dětí. Struktura studie: multicentrická, prospektivní, randomizovaná, dvojitě slepá kontrolovaná. 86 symptomatických na H. pylori pozitivních dětí bylo náhodně vybráno pro léčbu buďto kombinací omeprazolu, amoxicillinu a claritromycinu (OAC) 7 dní nebo kombinací omeprazolu, amoxicillinu a claritromycinu 7 dní v kombinaci s Actimelem obsahujícím L. casei DN-114 001 (OAC-LC) 14 dní. Po 4 týdnech terapie byl detekován H. pylori. Výsledky: eradikační úroveň intention-to-treat (ITT) byla u OAC-LC 84,6 % a 91,6 %. U skupiny OAC to bylo 57,5 % a 61,3 %. Primární rezistence byla zjištěna u 21,2 %. Nežádoucí účinky byly málo časté a drug compliance dobrá. Závěr: suplementace fermentovaného mléka obsahujícího specifické kmeny probiotického L. casei DN-114 001 zvyšuje léčebnou účinnost trojkombinace. (cs)
  • Goals: To determine the efficacy of triple therapy supplemented with a specially designed fermented milk product containing specific probiotic Lactobacillus casei (L. casei) DN-114 001 strain on Helicobacter pylori eradication in children. Background: Lactobacillus species possess in vitro activity against H. pylori. There are no consistent data on the impact of eradication therapy supplemented with probiotics on H. pylori cure rates in childhood in vivo. Conclusion: Supplementation with fermented milk, containing live special probiotic L casei DN-114 001, confers an enhanced therapeutic benefit on H. pylori eradication in children with gastritis on triple therapy.
  • Goals: To determine the efficacy of triple therapy supplemented with a specially designed fermented milk product containing specific probiotic Lactobacillus casei (L. casei) DN-114 001 strain on Helicobacter pylori eradication in children. Background: Lactobacillus species possess in vitro activity against H. pylori. There are no consistent data on the impact of eradication therapy supplemented with probiotics on H. pylori cure rates in childhood in vivo. Conclusion: Supplementation with fermented milk, containing live special probiotic L casei DN-114 001, confers an enhanced therapeutic benefit on H. pylori eradication in children with gastritis on triple therapy. (en)
Title
  • Effects of Specially Designed Fermented Milk Product Containing Probiotic Lactobacillus casei DN-114 001 and the Eradication of H. pylori in Children
  • Effects of Specially Designed Fermented Milk Product Containing Probiotic Lactobacillus casei DN-114 001 and the Eradication of H. pylori in Children (en)
  • Effects of a Specially Designed Fermented Milk Product Containing Probiotic Lactobacillus casei DN-114 001 and the Eradication of H. pylori in Children (cs)
skos:prefLabel
  • Effects of Specially Designed Fermented Milk Product Containing Probiotic Lactobacillus casei DN-114 001 and the Eradication of H. pylori in Children
  • Effects of Specially Designed Fermented Milk Product Containing Probiotic Lactobacillus casei DN-114 001 and the Eradication of H. pylori in Children (en)
  • Effects of a Specially Designed Fermented Milk Product Containing Probiotic Lactobacillus casei DN-114 001 and the Eradication of H. pylori in Children (cs)
skos:notation
  • RIV/00216208:11150/05:00004926!RIV08-MSM-11150___
http://linked.open.../vavai/riv/strany
  • 692;698
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • S
http://linked.open...iv/cisloPeriodika
  • 8
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 519622
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11150/05:00004926
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Effects; Specially; Designed; Fermented; Product; Containing; Probiotic; Lactobacillus; casei; DN-114; Eradication; pylori; Children (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [039EB5DA9BA9]
http://linked.open...i/riv/nazevZdroje
  • Journal of Clinical Gastroenterology
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 39
http://linked.open...iv/tvurceVysledku
  • Dědek, Petr
issn
  • 0192-0790
number of pages
http://localhost/t...ganizacniJednotka
  • 11150
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software